| Financial Year |
March 31 2023 |
| Monetary Funds |
261,046,985.51 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,028,826,669.05 |
| Advances to Suppliers |
8,626,205.79 |
| Other Receivables |
14,863,125.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
26,759,361.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
61,000,000.00 |
| Other Current Assets |
33,937,955.37 |
| Total Current Assets |
2,225,356,445.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
226,311,824.66 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
7,127,167.99 |
| Under-construction Projects |
951,538.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,270,142.92 |
| R&D expenses |
-- |
| Goodwill |
1,063,706.16 |
| Long-Term Deferred and Prepaid Expenses |
10,819,632.69 |
| Deferred Income Tax Assets |
97,221,903.80 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
376,916,729.12 |
| Total Assets |
2,602,273,174.73 |
| Short-Term Loans |
110,207,983.32 |
| Trading Financial liabilities |
-- |
| Notes Payable |
101,732,475.35 |
| Accounts Payable |
691,300,015.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,849,975.26 |
| Taxes Payable |
7,511,781.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,607,192.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
42,524,561.29 |
| Other Current Liabilities |
143,720,148.80 |
| Sub-Total of Current Liabilities |
1,149,400,492.95 |
| Long-term Loans |
50,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
9,033,020.26 |
| Deferred Income Tax Liabilities |
1,307,177.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
89,047,645.17 |
| Total Liabilities |
1,238,448,138.12 |
| Paid-In Capital(Or Share Stock) |
161,237,408.00 |
| Capital Surplus |
896,027,868.77 |
| Surplus Reserve |
64,839,123.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
236,854,652.98 |
| Minority Stockholder's Interest |
4,865,983.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,358,959,053.07 |
| Owner's Equity（Stockholder's Equity） |
1,363,825,036.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,602,273,174.73 |
